Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Trump announces second MFN pricing deal as AstraZeneca slashes drug costs for millions AstraZeneca to offer most-favored-nation drug prices to U.S. Medicaid and invest $50B in American pharma manufacturing. Find out what it means for patients. byVenkateshOctober 13, 2025